mRNA |
indisulam |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
3e-07 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
7e-07 |
mRNA |
barasertib |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
1e-06 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
1e-06 |
mRNA |
ABT-737 |
CTRPv2 |
pan-cancer |
AAC |
-0.18 |
2e-06 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
2e-05 |
mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
2e-05 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
4e-05 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
4e-05 |
mRNA |
CD-437 |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
5e-05 |